Comparing Wound Area Reduction of Non-healing DFUs Using MolecuLight i:X Versus Standard of Care
NCT: NCT04207099 · COMPLETED
Brief Summary
This is a 12 week, randomized controlled trial. There are 2 arms and 20 patients with non healing diabetic foot ulcer allocated in each arm. One arm receives i:X guided treatment and the other arm receives standard of care treatment. Our primary objective is to compare the wound area reduction in both arms.
Frequently Asked Questions
What is Comparing Wound Area Reduction of Non-healing DFUs Using MolecuLight i:X Versus Standard of Care?
Comparing Wound Area Reduction of Non-healing DFUs Using MolecuLight i:X Versus Standard of Care is a clinical trial registered under NCT04207099. Current status: COMPLETED.
What is the status of NCT04207099?
The current status of NCT04207099 (Comparing Wound Area Reduction of Non-healing DFUs Using MolecuLight i:X Versus Standard of Care) is: COMPLETED.
When did Comparing Wound Area Reduction of Non-healing DFUs Using MolecuLight i:X Versus Standard of Care start?
Comparing Wound Area Reduction of Non-healing DFUs Using MolecuLight i:X Versus Standard of Care started on 2020-02-14.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.